Seven people vaccinated with the AstraZeneca COVID-19 vaccine died after registering for a rare thrombotic event, UK drug regulators confirmed.
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced on April 1 that it has identified 30 thrombotic events after the use of AstraZeneca.
“Sadly seven of the 30 reports up to March 24 died,” MHRA said in a statement emailed to The Epoch Times.
However, regulators have emphasized that the benefits of the CCP (Chinese Communist Party) virus vaccine outweigh the risks.
Dr. June Raine, Chief Executive Officer of MHRA, said:
MHRA is the latest weekly summary of the side effects of the COVID-19 vaccine, with 22 reports of cerebral sinus thrombosis, very rare cerebral coagulopathy, and 8 other coagulation events associated with low platelets. He said he received the report. By that date, a total of 18.1 million doses had been administered.
Regulators said there were no reports of the Pfizer / BioNTech vaccine.
“We ask medical professionals to report cases suspected of being associated with COVID-19 vaccination via the Coronavirus Yellow Card website,” Dr. Rain said.
Like the MHRA, the European Medicines Agency Said The benefits of jabs outweigh the risk of side effects.
EU regulators reviewing thrombus events said on March 31 that the causal link between vaccines between thrombi was “unproven, but possible, and further analysis is ongoing.”
“Currently, this review does not identify specific risk factors such as age, gender, or history of coagulopathy for these very rare events,” he said.
Vaccine use is restricted in some countries due to concerns about blood clots.
On April 2, the Netherlands suspended the AstraZeneca vaccine for people under the age of 60 for the second time after a woman who received jabs died and four other women experienced serious complications. Did.
On March 30, German health officials agreed to limit the use of AstraZeneca jab in people under the age of 60 after 31 cases of blood clots were reported from approximately 2.7 million doses of AstraZeneca vaccine. Did.
France also said in mid-March that it had decided to limit the vaccine to people over the age of 55.
Lorenz Duchamps and Reuters contributed to this report.